CASSANDRA WREN: Open Payments
NPI 1003241084 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 58 payments from 15 companies in 2025. Trend: 2023 $1,621 · 2024 $1,638 · 2025 $1,198
Food & beverage: $1,098Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $262 |
| Amgen Inc. | 9 | $202 |
| Organon LLC | 4 | $185 |
| ABBVIE INC. | 10 | $180 |
| LEO Pharma Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| UCB, Inc. | 3 | $51 |
| GENZYME CORPORATION | 2 | $39 |
| PFIZER INC. | 2 | $33 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: TREMFYA, Otezla, SKYRIZI, VTAMA, Bimzelx, ANZUPGO, DUPIXENT, RINVOQ.
Industry payments across OR — which companies pay providers there.
